Pfizer Exits Early Neuroscience, But M&A Could Allow Later Re-Entry

 
• By Sten Stovall
Nerve cells
Analysts Unsurprized By Pfizer Exiting Early Neuroscience R&D • Source: Shutterstock

More from Strategy

More from Business